Aramark

ARMK

Market cap $9.77B

Alphabet shares rose 38% during the quarter. This represents a striking $810 billion increase in market value. Samsung shares rose 36% in the quarter, adding over $100 billion of market value. Samsung shares are finally starting to benefit from AI enthusiasm. Elevance's share price declined by 16%, making it our largest negative contributor.

PHILADELPHIA--(BUSINESS WIRE)--Aramark SeniorLife+ today announced the launch of a new Consultative Services program, designed to meet the needs of senior living communities, strengthen operations, and elevate resident experiences without entering traditional management contracts. “By listening and aligning our resources, technology, and programs around the client's mission, we can help communities improve services to enhance resident life and satisfaction,” said Joe Gorman, President and CEO o.

Shares of Aramark (NYSE:ARMK) fell around 6% on Monday after the company reported downbeat earnings for the fourth quarter.

Aramark ( ARMK ) Q4 2025 Earnings Call November 17, 2025 8:30 AM EST Company Participants Felise Kissell - Investor Relations & Corporate Affairs Executive John Zillmer - CEO & Director James Tarangelo - Senior VP & CFO Conference Call Participants Ian Zaffino - Oppenheimer & Co. Inc., Research Division Toni Kaplan - Morgan Stanley, Research Division Leo Carrington - Citigroup Inc., Research Division Andrew Steinerman - JPMorgan Chase & Co, Research Division Jaafar Mestari - BNP Paribas, Research Division Neil Tyler - Rothschild & Co Redburn, Research Division Jasper Bibb - Truist Securities, Inc., Research Division Andrew J. Wittmann - Robert W.

Although the revenue and EPS for Aramark (ARMK) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Aramark (ARMK) is upgraded to a 'BUY' rating with a maintained share price target, reflecting strong recent results and ongoing operational improvements. ARMK delivered double-digit operating income and EPS growth, record-high customer retention, and international expansion, despite market volatility and a modest dividend yield. While ARMK's fundamentals are improving, alternatives offer higher yields, lower valuations, and stronger credit ratings, making them more attractive sector picks.

Aramark (ARMK) came out with quarterly earnings of $0.64 per share, missing the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.54 per share a year ago.

PHILADELPHIA--(BUSINESS WIRE)--Aramark (NYSE: ARMK) today reported results for the fourth quarter and full year of fiscal 2025. “Fiscal 2025 represented many consequential milestones for the Company, contributing to the strong growth trajectory ahead,” said John Zillmer, Aramark CEO. “In addition to being awarded one of the most prestigious medical systems in the world, we delivered almost $1 billion in Annualized Net New business, added more than $1 billion of new purchasing spend in our Globa.

Aramark (NYSE: ARMK) will release earnings results for the fourth quarter, before the opening bell on Monday, Nov. 17.

Evaluate the expected performance of Aramark (ARMK) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.